ZFP109 inhibitors are a class of chemical compounds designed to specifically target zinc finger protein 109 (ZFP109), a transcription factor involved in regulating gene expression through its interaction with specific DNA sequences. Like other zinc finger proteins, ZFP109 contains zinc finger motifs, which are specialized structural domains that allow the protein to bind to DNA with high specificity. These motifs rely on the coordination of zinc ions to maintain their structural integrity, ensuring that ZFP109 can interact with its target DNA regions effectively. ZFP109 plays a crucial role in controlling the transcription of various genes, influencing a range of cellular processes. Inhibitors of ZFP109 function by disrupting this DNA-binding activity, either by destabilizing the zinc finger motifs or by blocking the protein's ability to interact with its target DNA sequences, ultimately leading to alterations in gene expression.
The mechanisms by which ZFP109 inhibitors operate can vary depending on their chemical structure and mode of action. One common mechanism involves chelating the zinc ions that are essential for maintaining the stability and proper conformation of the zinc finger domains. By binding to or sequestering these zinc ions, the inhibitors cause the zinc finger motifs to lose their functional conformation, rendering ZFP109 unable to bind to DNA. Without this ability, ZFP109 cannot regulate the transcription of its target genes, leading to disruptions in cellular processes dependent on its activity. Other inhibitors may function by blocking critical protein-protein interactions required for ZFP109 to form transcriptional complexes or interact with cofactors, further impairing its role in gene regulation. Studying ZFP109 inhibitors provides valuable insights into the broader mechanisms of zinc finger proteins and their influence on gene expression and cellular regulation, contributing to a deeper understanding of transcriptional control in biological systems.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D inhibits ZNF109 expression by intercalating into DNA, preventing the transcription of ZNF109-regulated genes, thereby reducing its expression levels. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Cycloheximide inhibits ZNF109 expression by blocking protein synthesis, leading to reduced levels of newly synthesized ZNF109 and impacting its regulatory functions. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
Puromycin inhibits ZNF109 expression by causing premature chain termination during protein synthesis, leading to reduced levels of functional ZNF109 protein. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $173.00 $418.00 | 43 | |
Doxorubicin inhibits ZNF109 expression by intercalating into DNA, disrupting the transcription of ZNF109-regulated genes, leading to decreased ZNF109 expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Cisplatin inhibits ZNF109 expression by forming DNA adducts, interfering with the binding of transcription factors to ZNF109-regulated genes, thus reducing its expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
5-Fluorouracil inhibits ZNF109 expression by interfering with DNA synthesis, disrupting the transcription of ZNF109-regulated genes, leading to reduced ZNF109 expression. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
Camptothecin inhibits ZNF109 expression by stabilizing the cleavable complex formed by topoisomerase I, leading to DNA damage and reduced ZNF109 expression. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $65.00 $99.00 $140.00 | 85 | |
Mitomycin C inhibits ZNF109 expression by forming DNA adducts, interfering with the binding of transcription factors to ZNF109-regulated genes, thus reducing its expression. | ||||||
Bleomycin | 11056-06-7 | sc-507293 | 5 mg | $270.00 | 5 | |
Bleomycin inhibits ZNF109 expression by causing DNA strand breaks and oxidative damage, leading to reduced ZNF109 expression. | ||||||
Idarubicin | 58957-92-9 | sc-507346 | 10 mg | $180.00 | ||
Idarubicin inhibits ZNF109 expression by intercalating into DNA, disrupting the transcription of ZNF109-regulated genes, leading to decreased ZNF109 expression. |